Chemoimmunotherapy in the systemic treatment of advanced renal carcinoma;Chemoimmuntherapie des fortgeschrittenen nierenzellkarzinoms

Urologe - Ausgabe A

Volumn 38, Issue 5, 1999, Pages 474-478

  Atzpodien, J ^a   Buer, J ^a   Sel, S ^a   Janssen, J ^a   Oevermann, K ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

interferon; 13 cis retinoic acid; Chemoimmunotherapy; Interleukin 2; Renal cell carcinoma

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 2; RETINOIC ACID;

ADVANCED CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG MEGADOSE; KIDNEY CARCINOMA; REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, RENAL CELL; COMBINED MODALITY THERAPY; HUMANS; INTERFERON-ALPHA; INTERLEUKIN-2; KIDNEY NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME; TRETINOIN;

EID: 0032828581     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001200050316     Document Type: Review

References (1)

1. http://link.springer.de/link/service/ journals/00120/index.htm